Citadel Advisors’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,397
| Closed | -$3.77K | – | 6795 |
|
|
2023
Q1 | $3.77K | Sell |
5,397
-4,515
| -46% | -$3.15K | ﹤0.01% | 5636 |
|
|
2022
Q4 | $8.92K | Buy |
+9,912
| New | +$8.92K | ﹤0.01% | 5702 |
|
|
2022
Q3 | – | Sell |
-150,954
| Closed | -$624K | – | 7042 |
|
|
2022
Q2 | $624K | Sell |
150,954
-34,656
| -19% | -$143K | ﹤0.01% | 3925 |
|
|
2022
Q1 | $706K | Sell |
185,610
-890,010
| -83% | -$3.39M | ﹤0.01% | 4086 |
|
|
2021
Q4 | $4.84M | Buy |
1,075,620
+3,006
| +0.3% | +$13.5K | ﹤0.01% | 2126 |
|
|
2021
Q3 | $5M | Sell |
1,072,614
-154,218
| -13% | -$719K | ﹤0.01% | 2040 |
|
|
2021
Q2 | $8.63M | Sell |
1,226,832
-10,666
| -0.9% | -$75K | ﹤0.01% | 1570 |
|
|
2021
Q1 | $7.31M | Buy |
1,237,498
+872,713
| +239% | +$5.16M | ﹤0.01% | 1700 |
|
|
2020
Q4 | $1.68M | Sell |
364,785
-22,528
| -6% | -$104K | ﹤0.01% | 2745 |
|
|
2020
Q3 | $1.51M | Sell |
387,313
-640,807
| -62% | -$2.49M | ﹤0.01% | 2550 |
|
|
2020
Q2 | $29.6M | Buy |
1,028,120
+7,703
| +0.8% | +$222K | 0.01% | 596 |
|
|
2020
Q1 | $22M | Buy |
1,020,417
+2,935
| +0.3% | +$63.2K | 0.01% | 637 |
|
|
2019
Q4 | $20M | Buy |
1,017,482
+59,100
| +6% | +$1.16M | 0.01% | 797 |
|
|
2019
Q3 | $14.4M | Buy |
+958,382
| New | +$14.4M | 0.01% | 984 |
|